Please wait while the formulary information is being retrieved.
ORAL ANALGESIC (benzocaine)
- Administration of local anesthesia
- Mouth irritation
- Suppression of the gag reflex
- Oral Pain Relief Mucosal Gel
- Oral Anesthetic Mucosal Gel
- Oral Analgesic Mucosal Solution
- Oral Analgesic Mucosal Gel
- Intense Toothache Pain Relief Mucosal Gel
- Hurricaine Mucosal Solution
- Hurricaine Mucosal Gel
- Benz-o-sthetic Mucosal Solution
- Benz-o-sthetic Mucosal Gel
- Anesthetic Oral Gel
- Anbesol (benzocaine) Maximum Strength Mucosal Gel
20 % mucosal gel
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 % mucosal solution
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 % mucosal solution
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 % mucosal solution
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 %
- Dosage information is not available
(benzocaine) Maximum Strength 20 % mucosal gel
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Methemoglobinemia
Contraindicated
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Hemolytic anemia from PK and g6PD deficiencies
- NADH methemoglobin reductase deficiency
- Systemic mastocytosis
Severe
Moderate
- None
ORAL ANALGESIC (benzocaine)
- Administration of local anesthesia
- Mouth irritation
- Suppression of the gag reflex
- None
- None
More Frequent
Severe
Less Severe
- Angioedema
- Contact dermatitis
- Erythema
- Mouth irritation
- Pruritus of skin
- Skin rash
- Urticaria
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Methemoglobinemia
Less Severe
- None
Contraindicated
Benzocaine (Oral,muc memb)
Increased risk for developing methemoglobinemia. Avoid use in infant or child age < 2 years.
- 1 Day – 2 Years
- 1 Increased risk for developing methemoglobinemia. Avoid use in infant or child age < 2 years.
Severe Precaution
Benzocaine (Oral,muc memb)
Increased risk for developing methemoglobinemia. Consult clinician prior to use.
- 2 Years – 6 Years
- Increased risk for developing methemoglobinemia. Consult clinician prior to use.
Management or Monitoring Precaution
None
Benzocaine(systemic)
- Severity Level:
D
- Additional Notes: Briggs does not recommend use on mucous membranes
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Benzocaine
Reports of infant methemoglobinemia after ingestion of topical benzocaine
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | No adverse effect | Reports of infant methemoglobinemia after ingestion of topical benzocaine |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Select Anesthetics
General-May be more sensitive to CNS and cardiac adverse reactions. Consider dose reduction due to reduced clearance in the elderly.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Mouth irritation | |
| K13.79 | Other lesions of oral mucosa |
| 0-9 | A-Z |
|---|---|
| K13.79 | Other lesions of oral mucosa |
Formulary Reference Tool